Skip to main content

Table 4 Treatment uptake as defined by percentage of eligible study participants who received treatment, with eligibility for treatment determined by hepatitis C RNA-positive status and other criteria

From: A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region

Author, year % treated (# treated/# of treatment candidates) SVR (%) (# with sustained viral response/# treated)
Defossez et al, 2008 24% (13/55)1 NA
Grando-Lemaire et al, 2002 58% (27/47) Intent-to-treat: 19% (5/27)
As-treated: 33% (5/15)
Jack et al, 2009 70% (30/43) Intent-to-treat: 62% (13/21)
As-treated: 77% (13/17)
Jowett et al, 2000 50% (50/100) Intent-to-treat: 36% (18/50)
Kristensen et al, 2009 33% (6/9) NA
Lindenburg et al, 2011 76% (58/76) Intent-to-treat: 65% (37/57)
As-treated: 77% (37/48)
  1. 1. Study population represents study cohorts from a cross-sectional survey carried out at three time points: 1997 (N=26), 2000 (N=11) and 2003 (N=18).